- Home
- ELVN vs BUSE Comparison
ELVN vs BUSE Comparison
Compare ELVN & BUSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ELVN | BUSE |
|---|---|---|
| Founded | 2016 | 1868 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.1B |
| IPO Year | 2020 | 1996 |
Fundamental Metrics
Financial Performance| Metric | ELVN | BUSE |
|---|---|---|
| Price | $43.66 | $26.58 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 7 |
| Target Price | ★ $43.40 | $27.00 |
| AVG Volume (30 Days) | ★ 1.6M | 575.2K |
| Earning Date | 05-13-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 3.88% |
| EPS Growth | ★ 3.17 | N/A |
| EPS | N/A | ★ 1.47 |
| Revenue | N/A | ★ $719,584,000.00 |
| Revenue This Year | N/A | $23.87 |
| Revenue Next Year | N/A | $3.82 |
| P/E Ratio | ★ N/A | $18.23 |
| Revenue Growth | N/A | ★ 55.66 |
| 52 Week Low | $14.79 | $19.55 |
| 52 Week High | $46.31 | $27.65 |
Technical Indicators
Market Signals| Indicator | ELVN | BUSE |
|---|---|---|
| Relative Strength Index (RSI) | 67.89 | 62.69 |
| Support Level | $18.04 | $23.78 |
| Resistance Level | N/A | $27.65 |
| Average True Range (ATR) | 2.71 | 0.46 |
| MACD | 0.41 | 0.17 |
| Stochastic Oscillator | 76.38 | 80.62 |
Price Performance
Historical ComparisonAbout ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
About BUSE First Busey Corporation
First Busey Corporation is a financial holding company whose subsidiaries provide retail and commercial banking services, remittance processing, and offer financial products and services with banking centers in Illinois, Missouri, Florida, and Indiana. The company's operations are managed through three operating segments consisting of Banking, FirsTech, and Wealth Management. The banking segment generates a vast majority of its revenue.